English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Electronics Nanotech & Materials
田中贵金属:作为液态钌前驱物实现了世界级行业标准蒸汽压力数值 开发了CVD/ALD用前驱物“TRuST”
Oct 09, 2020 19:00 HKT
Impact BioMedical to Begin Efficacy Testing Pan-Coronavirus Vaccine Under New Wholly Owned Subsidiary Innate Immune, Inc.
Oct 05, 2020 15:25 HKT
田中贵金属:作为液态钌前驱物实现了世界级行业标准蒸汽压力数值 开发了CVD/ALD用前驱物“TRuST”
Oct 05, 2020 13:00 HKT
田中貴金屬:以液體釕前驅物實現世界最高水準的蒸氣壓値 開發CVD與ALD用前驅物「TRuST」
Oct 05, 2020 13:00 HKT
TANAKA Develops "TRuST" Precursor for CVD/ALD Processes; Using Liquid Ruthenium Precursor to Achieve World's Highest Vapor Pressures
Sep 30, 2020 10:00 HKT
Impact BioMedical Demonstrates 10-Fold Reduction in Viral Population of COVID-19 in Surface Disinfectant Efficacy Testing of its 3F Antiviral Biofragrance
Sep 18, 2020 17:00 HKT
TANAKA Wins Award in Industry of FY2019 FCDIC Honoring System
Sep 10, 2020 10:00 HKT
TANAKA Memorial Foundation to Offer Precious Metals Research Grants of up to 5 Million Yen
Sep 01, 2020 10:00 HKT
TANAKA Selected in Ministry of Economy, Trade, and Industry's 2020 Global Niche Top Companies
Aug 05, 2020 10:00 HKT
田中贵金属:入选2020年版“日本经济产业省认定国际利基领军企业”
Aug 05, 2020 10:00 HKT
田中貴金屬:經選定為2020年版「經濟產業省認證全球利基型(Global Niche Top)企業」
Aug 05, 2020 10:00 HKT
다나까 귀금속 공업:2020년도 ‘일본경제산업성 인정 글로벌니치(틈새) 톱 기업’으로 선정
Aug 05, 2020 10:00 HKT
Using AI to predict new materials with desired properties
Aug 01, 2020 03:00 HKT
Impact Biomedical initiates Quantum, a new frontier in Pharmaceutical Development
Jul 31, 2020 15:00 HKT
Let the robot swarms begin!
Jun 21, 2020 18:00 HKT
TANAKA Memorial Foundation Announces Recipients of Precious Metals Research Grants
Mar 31, 2020 11:00 HKT
Bringing the green revolution to electronics
Feb 28, 2020 16:00 HKT
Gaining more control over fuel cell membranes
Feb 21, 2020 08:00 HKT
Using bone's natural electricity to promote regeneration
Feb 13, 2020 01:00 HKT
Combined data approach could accelerate development of new materials
Feb 11, 2020 16:00 HKT
Next >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: